RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1

Cervical cancer ranks as the fourth most common malignant tumor among women worldwide. However, the molecular mechanisms driving tumor progression and immune evasion in this disease have not been sufficiently clarified. The aim of this study was to determine the expression profile and clinical significance of ring finger protein 112 (RNF112) in cervical cancer and to elucidate the molecular mechanism by which RNF112 regulates tumor proliferation and immune response.